These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19810166)

  • 1. Why ceftazidime?
    Muggleton PW
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():1-3. PubMed ID: 19810166
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftazidime: summary of the first international symposium.
    Young LS
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():349-52. PubMed ID: 19803013
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.
    Farfour E; Trochu E; Devin C; Cardot Martin E; Limousin L; Roux A; Picard C; Jolly E; Vasse M; Lesprit P
    Transpl Infect Dis; 2018 Oct; 20(5):e12955. PubMed ID: 29896802
    [No Abstract]   [Full Text] [Related]  

  • 4. The microbiological assay of ceftazidime.
    Thornton JE
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():225-6. PubMed ID: 19802989
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacteriological investigations with ceftazidime in vitro.
    Grimm H
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():213-6. PubMed ID: 19802986
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceftazidime regression studies.
    Crosse R; Burt DG; Gardner MJ
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():221-3. PubMed ID: 19802988
    [No Abstract]   [Full Text] [Related]  

  • 7. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
    Vanhoof R; Gordts B; Coignau H; Stas G; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():63-6. PubMed ID: 19802970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin.
    Harris AM; Plested SJ; Harper PB
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():43-5. PubMed ID: 19810168
    [No Abstract]   [Full Text] [Related]  

  • 9. Behaviour of ceftazidime towards beta-lactamases.
    Labia R; Beguin-Billecoq R; Guionie M
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():141-6. PubMed ID: 19810176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin, ceftazidime, and moxifloxacin can be safely stored in single-use, polypropylene syringes.
    Armstrong BK; Mehta S; Kim SJ
    Retina; 2011 Nov; 31(10):2134-6. PubMed ID: 22027802
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftazidime: comparative in-vitro study.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
    Cafini F; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; González N; Coronel P; Prieto J
    Rev Esp Quimioter; 2010 Jun; 23(2):72-5. PubMed ID: 20559604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
    Neu HC
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in-vitro properties of ceftazidime.
    Harper PB
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():5-13. PubMed ID: 19802965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro activity of ceftazidime against clinically important pathogens.
    Knothe H; Dette GA
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime (Fortaz).
    Med Lett Drugs Ther; 1985 Oct; 27(698):85-7. PubMed ID: 3900663
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of ceftazidime in severe Gram-negative infections--a preliminary study.
    Clumeck N; Vanlaethem Y; Gordts B; Jaspar N; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():317-21. PubMed ID: 19803007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The susceptibility of nosocomial pathogens to ceftazidime.
    Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():15-21. PubMed ID: 19802966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empowering Older Antibiotics.
    Wright GD
    Cell; 2016 Oct; 167(2):301. PubMed ID: 27716499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.